Finland· FI-REL-REL7707

Levobellal

A belladonna-gesamtalkaloide mit psycholeptika product, registered in Finland by Schering Oy.

ATC A03CB02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedLevobellalATCA03CB02REGISTER NO.FI-REL-REL7707PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Schering Oy
Country
Finland (FI)
ATC code
A03CB02
ATC class
Belladonna-Gesamtalkaloide mit Psycholeptika
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A03CB02

Belladonna-gesamtalkaloide mit psycholeptika, as other registers publish it.

All belladonna-gesamtalkaloide mit psycholeptika products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d7f85daa-c610-4a5c-91da-46415d67a902
GET /v1/drugs/d7f85daa-c610-4a5c-91da-46415d67a902?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "tabletti",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "belladonna-alkaloidit ja psyykenlääke",
  "ma_number": "4662",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7707",
  "authorised_at": "1967-04-19"
}

See everything about belladonna-gesamtalkaloide mit psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.